Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates the biological effects of peroxisome proliferators. To determine the physiological role of PPARalpha in cardiac fatty acid metabolism, we examined the regulation of expression of cardiac fatty acid-metabolizing proteins using PPARalpha-null mice. The capacity for constitutive myocardial beta-oxidation of the medium and long chain fatty acids, octanoic acid and palmitic acid, was markedly reduced in the PPARalpha-null mice as compared with the wild-type mice, indicating that mitochondrial fatty acid catabolism is impaired in the absence of PPARalpha. In contrast, constitutive beta-oxidation of the very long chain fatty acid, lignoceric acid, did not differ between the mice, suggesting that the constitutive expression of enzymes involved in peroxisomal beta-oxidation is independent of PPARalpha(.) Indeed, PPARalpha-null mice had normal levels of the peroxisomal beta-oxidation enzymes except the D-type bifunctional protein. At least seven mitochondrial fatty acid-metabolizing enzymes were expressed at much lower levels in the PPARalpha-null mice, whereas other fatty acid-metabolizing enzymes were present at similar or slightly lower levels in the PPARalpha-null, as compared with wild-type mice. Additionally, lower constitutive mRNA expression levels of fatty acid transporters were found in the PPARalpha-null mice, suggesting a role for PPARalpha in fatty acid transport and catabolism. Indeed, in fatty acid metabolism experiments in vivo, myocardial uptake of iodophenyl 9-methylpentadecanoic acid and its conversion to 3-methylnonanoic acid were reduced in the PPARalpha-null mice. Interestingly, a decreased ATP concentration after exposure to stress, abnormal cristae of the mitochondria, abnormal caveolae, and fibrosis were observed only in the myocardium of the PPARalpha-null mice. These cardiac abnormalities appeared to proceed in an age-dependent manner. Taken together, the results presented here indicate that PPARalpha controls constitutive fatty acid oxidation, thus establishing a role for the receptor in cardiac fatty acid homeostasis. Furthermore, altered expression of fatty acid-metabolizing proteins seems to lead to myocardial damage and fibrosis, as inflammation and abnormal cell growth control can cause these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiac specific knockout of PPARα causes deficiencies in mitochondrial β-oxidation, leading to eventual myocardial damage and fibrosis [113].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationPeroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Self-citationThe PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Self-citationActivation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., & Grimaldi, P. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46753-6 · Cited by 1,002
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 872
Research works printed but not linked: 4
- 9. Chouraqui, P. ∙ Maddahi, J. ∙ Henkin, R. ... J. Nucl. Med. 1991; 32:447-452 PubMed Google Scholar
- Lefer, 1985, Fed. Proc., 44, 275
- Lefer, 1987, Arch. Int. Pharm. Ther., 287, 89
- Lefer, 1987, Cardiovasc. Clin., 18, 85
Cited by
Items 201–300 of 330
Attenuation of cytotoxicity induced by tBHP in H9C2 cells by Bacopa monniera and Bacoside A
Mohan Manu, T., Anand, T., & Khanum, F. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.03.002 · Cited by 21
Huang, Q., Huang, J., Zeng, Z., Luo, J., Liu, P., Chen, S., Liu, B., Pan, X., Zang, L., & Zhou, S. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.015 · Cited by 20
Mitochondrial biogenesis in organismal senescence and neurodegeneration
Daskalaki, I., & Tavernarakis, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111345 · Cited by 19
Effects of short‐chain acyl‐CoA dehydrogenase on cardiomyocyte apoptosis
Zeng, Z., Huang, Q., Shu, Z., Liu, P., Chen, S., Pan, X., Zang, L., & Zhou, S. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12828 · Cited by 19
Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathy
Drosatos, K. (2016) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v6.32221 · Cited by 19
Xie, W., Zhang, W., Ren, J., Li, W., Zhou, L., Cui, Y., Chen, H., Yu, W., Zhuang, X., Zhang, Z., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05220 · Cited by 19
Azimzadeh, O., Subramanian, V., Sievert, W., Merl‐Pham, J., Oleksenko, K., Rosemann, M., Multhoff, G., Atkinson, M. J., & Tapio, S. (2021) · Biomedicines · doi:10.3390/biomedicines9121845 · Cited by 19
Changes in short‐chain acyl‐coA dehydrogenase during rat cardiac development and stress
Huang, J., Xu, L., Huang, Q., Luo, J., Liu, P., Chen, S., Yuan, X., Lu, Y., Wang, P., & Zhou, S. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12541 · Cited by 18
Ahmed, S. H., Koubaa, N., Kharroubi, W., Zarrouk, A., Bhouri, A. M., Batbout, F., Gamra, H., Hammami, S. O., Lizard, G., & Hammami, M. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.08.001 · Cited by 18
Baranowski, M., Blachnio-Zabielska, A., & Górski, J. (2009) · PubMed · Cited by 17
Mitochondrial Homeostasis Mediates Lipotoxicity in the Failing Myocardium
Kretzschmar, T., Wu, J. M. F., & Schulze, P. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031498 · Cited by 17
Yuan, J., Jian, W. U., Hang, Z.-G., ZHONG, X.-K., Zhou, L.-W., & Yu, B. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200808020-00013 · Cited by 17
Hoffmann, L., Seibt, A., Herebıan, D., & Spiekerkoetter, U. (2013) · Lipids · doi:10.1007/s11745-013-3865-4 · Cited by 17
Miyamoto, T., Takeishi, Y., Tazawa, S., Inoue, M., Aoyama, T., Takahashi, H., Arimoto, T., Shishido, T., Tomoike, H., & Kubota, I. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01312.x · Cited by 17
Self-citationPPARα activators may be good candidates as antiaging agents
Erol, A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.01.040 · Cited by 17
Lu, Y., Harada, M., Kamijo, Y., Nakajima, T., Tanaka, N., Sugiyama, E., Kyogashima, M., Gonzalez, F. J., & Aoyama, T. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2335-4 · Cited by 16
Self-citationKim, Y., Choi, J.-Y., Lee, S.-H., Lee, B. H., Yoo, H., & Han, Y. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0342 · Cited by 16
Finck, B. N. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.161 · Cited by 17
Tanaka, N., Hora, K., Makishima, H., Kamijo, Y., Kiyosawa, K., Gonzalez, F. J., & Aoyama, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00423-x · Cited by 15
Self-citationRubio‐Tomás, T., Soler‐Botija, C., Martínez-Estrada, O. M., & Villena, J. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116185 · Cited by 14
PPARα: its role in the human metabolic syndrome
Azhar, S., & Kelley, G. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.31 · Cited by 14
Proteomics landscape of radiation-induced cardiovascular disease: somewhere over the paradigm
Azimzadeh, O., & Tapio, S. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1388743 · Cited by 14
PPARδ, a Potential Therapeutic Target for Heart Disease
Yang, Q., & Long, Q. (2018) · Nuclear Receptor Research · doi:10.32527/2018/101375 · Cited by 14
Li, Y., Sugiyama, E., Yokoyama, S., Jiang, L., Tanaka, N., & Aoyama, T. (2008) · Lipids · doi:10.1007/s11745-008-3161-x · Cited by 14
Self-citationRegulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH
Bogazzi, F., Raggi, F., Ultimieri, F., Russo, D., D’Alessio, A., Manariti, A., Brogioni, S., Manetti, L., & Martino, E. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0194 · Cited by 14
Ming, S., Kan, M., Liu, L., Zhang, Z., Liu, X., Liu, Y., Li, Z., Zhang, Y., Pang, Q., Lin, J., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3188292 · Cited by 13
ERBB2 Deficiency Alters an E2F-1-Dependent Adaptive Stress Response and Leads to Cardiac Dysfunction
Perry, M.-C., Dufour, C. R., Eichner, L. J., Tsang, D. W. K., Deblois, G., Muller, W. J., & Giguère, V. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00895-14 · Cited by 13
Ortona, S., Barisione, C., Ferrari, P. F., Palombo, D., & Pratesi, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133638 · Cited by 13
Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice
Chen, W., Chen, W., Xia, Y., Zhao, X., Wang, H., Mao-hua, Y., Li, Y., Ye, H., & Zhang, Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2325-1 · Cited by 13
Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease
Paredes, A. L., Santos-Clemente, R., & Ricote, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157775 · Cited by 13
PPARα is down-regulated following liver transplantation in mice
Nakagawa, K., Tanaka, N., Morita, M., Sugioka, A., Miyagawa, S.-I., Gonzalez, F. J., & Aoyama, T. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.021 · Cited by 13
Self-citationChanges to PUFA-PPAR pathway during mesaconitine induced myocardial coagulative necrosis
Chen, Q., Deng, X., Zhang, K., Kang, Y., Jiao, M., Zhang, J., Wang, C., & Li, F. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113831 · Cited by 12
Kanagaratham, C., Chiwara, V., Ho, B., Moussette, S., Youssef, M., Venuto, D., Jeannotte, L., Bourque, G., Sanctis, J. B. D., Radzioch, D., et al. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9743-x · Cited by 12
The role of PPARs in modulating cardiac metabolism in diabetes
Holness, M. J., Samsuddin, S., & Sugden, M. C. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.006 · Cited by 11
Arias, T., Beaumont, J., López, B., Zalba, G., Beloqui, Ó., Barba, J., Valencia, F., Gómez‐Doblas, J. J., de Teresa, E., & Díez, J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455027 · Cited by 11
Rao, M., Guo, G., Li, M., Shi, C., Chen, K., Chen, X., Song, J., & Hu, S. (2019) · Clinical Genetics · doi:10.1111/cge.13642 · Cited by 11
PPARα Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF-κB Signaling
Hashimoto, K., Kamijo, Y., Nakajima, T., Harada, M., Higuchi, M., Ehara, T., Shigematsu, H., & Aoyama, T. (2012) · PPAR Research · doi:10.1155/2012/976089 · Cited by 11
Self-citationThe Relationship Between KLF5 and PPARα in the Heart: It’s Complicated
Roe, N. D., Standage, S. W., & Tian, R. (2016) · Circulation Research · doi:10.1161/circresaha.115.308069 · Cited by 11
Ketone Catabolism Is Essential for Maintaining Normal Heart Function During Aging
Keller, M. A., & Nakamura, M. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.042508 · Cited by 10
Comella, F., Aragón‐Herrera, A., Pirozzi, C., Feijóo‐Bandín, S., Lama, A., Opallo, N., Melini, S., Piano, F. D., Gualillo, O., Meli, R., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123226 · Cited by 10
Peng, H., Xie, M., Zhong, X., Su, Y., Qin, X., Xu, Q., & Zhou, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175849 · Cited by 10
Oxidative Stress and Heart Failure
Chen, Q. M., Morrissy, S. J., & Alpert, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65249-2 · Cited by 11
Sheng, X., Nakajima, T., Wang, L., Zhang, X., Kamijo, Y., Takahashi, K., Tanaka, N., Sugiyama, E., Kyogashima, M., Aoyama, T., et al. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.227.1 · Cited by 10
Self-citationMicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy
De, A., Sarkar, A., Banerjee, T., Bhowmik, R., Sar, S., Shaharyar, M. A., Karmakar, S., & Ghosh, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1613844 · Cited by 9
Tian, Y., Yang, Y., Zhang, X., Nakajima, T., Tanaka, N., Sugiyama, E., Kamijo, Y., Lu, Y., Moriya, K., Koike, K., et al. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9703-1 · Cited by 9
Self-citationRejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 9
Cardiac lipotoxic effects of obesity
Асташкин, Е. И., & Глезер, М. Г. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-3-335-341 · Cited by 8
Beaumont, J., Arias, T., López, B., González, A., Ravassa, S., Hermida, N., Querejeta, R., & Díez, J. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75252-4 · Cited by 8
Molecular Determinants of the Cardiometabolic Phenotype
Fuentes, L. D. L., SIMONE, G. D., Arnett, D. K., & Dávila‐Román, V. G. (2010) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213119 · Cited by 8
The Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel?
Masoud, W. G. T., Clanachan, A. S., & Lopaschuk, G. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_4 · Cited by 7
Transcriptome Analysis of Skeletal Muscle in Pigs with Divergent Residual Feed Intake Phenotypes
Hou, X., Pu, L., Wang, L., Liu, X., Gao, H., Yan, H., Zhang, J., Zhang, Y., Yue, J., Zhang, L., et al. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.4878 · Cited by 7
Has Angiogenesis Been Invited to the PPARty?
Barger, P. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2029 · Cited by 7
Yang, Q., Yin, X., Li, H., Ding, L., Sun, H., Li, Y., & Li, Z. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231183885 · Cited by 6
Roy, R., Leigh, T., Gao, E., Zhang, X., & Tian, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/667964 · Cited by 6
Zong, X., Zhu, L., Wang, Y., Wang, J., Gu, Y., & Liu, Q. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09943-5 · Cited by 5
Ahire, Y. S., Dandawate, P. R., Ghaisas, M. M., & Gandhi, S. (2013) · Chronicles of young scientists · doi:10.4103/2229-5186.108809 · Cited by 5
Nuclear receptors and skeletal muscle fiber type
Mizunoya, W. (2015) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.4.259 · Cited by 5
Dodd, M. S., Ambrose, L. J. A., Ball, V., Clarke, K., Carr, C. A., & Tyler, D. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118599 · Cited by 4
FNDC4 Prevents Aging-Related Cardiac Dysfunction
Zhang, X., Dong, W.-S., Li, K., Ye, Y.-J., & Hu, C. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.01.004 · Cited by 4
Arias-Amézquita, F., Otero, J. M., Londoño, E., Becerra, H., Carvajalino, S., Rodríguez, C. I., Granados, J., Quintero, P., Mora, M., Castro, C., et al. (2012) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2012.03.001 · Cited by 4
Luo, J., Xu, L., Li, J., & Zhao, S. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0692-x · Cited by 4
Do PPARs play a role in cardiac hypertrophy and heart failure?
Tian, Q., & Barger, P. M. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.011 · Cited by 4
Sugiyama, E., Tanaka, N., Nakajima, T., Kamijo, Y., Yokoyama, S., Li, Y., Gonzalez, F. J., & Aoyama, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.048 · Cited by 4
Self-citationIgarashi, N., Nozawa, T., Fujii, N., Kato, B., Nonomura, M., Matsuki, A., Nakadate, T., Igawa, A., Asanoi, H., Inoue, M., et al. (2005) · PubMed · Cited by 4
Effect of berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats
Jiyin, Z., Shiwen, Z., Jianlin, T., Xu, Y. X., & Ying, Y. (2008) · 中国人民解放军军医大学学报:英文版 · doi:10.1016/s1000-1948(08)60008-8 · Cited by 3
Watanabe, K., Arozal, W., Tanaka, H., Ma, M., Satoh, S., Veeraveedu, P. T., Kobayashi, T., Ōyama, H., & Sakaguchi, Y. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-241 · Cited by 3
Self-citationIschemic preconditioning accelerates the fatty acid oxidation of rat hearts
Matsuki, A., Nozawa, T., Igawa, A., Igarashi, N., Nakadate, T., Fujii, N., & Inoue, H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.014 · Cited by 3
Yang, J., Liu, C., Jihang, Z., Yu, J., Dai, L., Ding, X., Qiu, Y., Yu, S., Yang, Y., Wu, Y., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.919 · Cited by 3
Bianchi, M., Panera, N., Petrillo, S., Cicolani, N., Stefanis, C. D., Scarsella, M., Ciavardelli, D., Piemonte, F., Alisi, A., & Pastore, A. (2025) · Antioxidants · doi:10.3390/antiox14091059 · Cited by 2
Quantitative Reverse Transcriptase Polymerase Chain Reaction
Gommersall, L. M., Arya, M., Patel, P. S., & PATEL, H. R. H. (2007) · Springer eBooks · doi:10.1007/978-1-84628-740-4_8 · Cited by 2
PPAR/PGC-1 Regulation of Metabolism in Cardiac Disease
Duncan, J. G., & Finck, B. N. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_4 · Cited by 2
Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure
Kolwicz, S. C., & Tian, R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_11 · Cited by 2
Yu, X., Zhao, X., Bao, R.-Q., Yu, J.-Y., Zhang, G., & Chen, J. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9238512 · Cited by 2
Cardiac effects of acute administration of a protonophore in a rat model
Muta, E., Kato, T., Shioi, T., Tanada, Y., & Kimura, T. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12956 · Cited by 2
Sose, P. M., Kale, P. P., & Doshi, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527323666230904150841 · Cited by 2
Jia, Y., Chang, H., Schipma, M. J., Liu, J., Shete, V., Liu, N., Sato, T., Thorp, E. B., Barger, P. M., Zhu, Y.-J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164316 · Cited by 2
PPARα: Linking Cardiac Metabolism to Therapeutic Opportunities in Cardiovascular Diseases
Roes, M., Libert, C., & Vandewalle, J. (2026) · Cells · doi:10.3390/cells15100940 · Cited by 1
Transcriptional regulation of cellular fatty acid homeostasis
van Bilsen, M. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)33016-4 · Cited by 1
Brown, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-40458-5_29 · Cited by 1
Fetal Origins of Adult Disease
Friedman, J., & Baker, P. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00015-9 · Cited by 1
The Role of PPARα in Fatty Acid Metabolism and Hepatocarcinogenesis: Studies with PPARα-Null Mice
Gonzalez, F. J. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1171-7_9 · Cited by 1
Self-citationTranscriptional Control of Mitochondrial Biogenesis and Maturation
Vega, R. B., Leone, T. C., & Kelly, D. P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_6 · Cited by 1
PPARs as Modulators of Cardiac Metabolism and Inflammation
Planavila, A., & van Bilsen, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800039-7.00011-6 · Cited by 1
Left ventricular hypertrophy and the insulin resistance syndrome
Sundström, J. (2001) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
dos Santos, M. H. H. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2011.tde-19032010-134026 · Cited by 1
Fatty Acid and Glucose Metabolism in Cardiac Disease
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50016-4 · Cited by 1
Cevey, Á. C. (2018) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires) · Cited by 1
Cardiac Remodeling and Cell Death in Heart Failure
Marín-García, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_11
Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart
Diep, Q. N., Amiri, F., & Schiffrin, E. L. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8047-3_20
Myocardial metabolism in experimental infarction and heart failure
Råmunddal, T. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Fat in hearts: Uptake, storage, and turnover
Trent, C. M. (2014) · doi:10.7916/d8c53j0x
Fischer, S. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13699
Hartil, K., & Charron, M. J. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.11.001
Glucose oxidation in heart-type fatty acid binding protein null mice
Adhikari, S. (2006) · OakTrust (Texas A&M University Libraries)
Heart- and liver-type fatty acid binding proteins in lipid and glucose metabolism
Erol, E. (2004) · OakTrust (Texas A&M University Libraries)
Molecular and Cellular Methodologies: A Primer
Marín-García, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_3
The Cardiac Fatty Acid Metabolic Pathway in Heart Failure
Morgan, E. E. (2006) · OhioLink ETD Center (Ohio Library and Information Network)
PAN-induced nephrotic rats Disorder of fatty acid metabolism in the kidney of
Nakamura, Y., Joh, K., Kohzuki, M., Muroya, Y., Ito, O., Rong, R., Takashima, K., Ito, D., & Cao, P. (2016)
Metadata
- Authors
- Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., Kamijo, Y., Gonzalez, F. J., & Aoyama, T.
- Affiliations
- Niigata University of Pharmacy and Medical and Life Sciences (JP)
- Niigata University (JP)
- Shinshu University (JP)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 29
- Pages
- 22293-22299
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2099834627
- Cited by
- 314
- References
- 43
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 12 · 2020: 8 · 2019: 10 · 2018: 13 · 2017: 16 · 2016: 16 · 2015: 17 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7401 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, cardiac fatty acid metabolism, PPARalpha-null mice, fatty acid transporters, peroxisomal beta-oxidation, lignoceric acid, myocardial fibrosis, caveolae, mitochondrial cristae, nuclear receptors
- MeSH terms
- Aging, Animals, Fatty Acids, Myocardium, Nuclear Proteins, Oxidation-Reduction, Transcription Factors, Immunoblotting, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.